Literature DB >> 10878068

Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile-associated diarrhea.

M J Alfa1, A Kabani, D Lyerly, S Moncrief, L M Neville, A Al-Barrak, G K Harding, B Dyck, K Olekson, J M Embil.   

Abstract

Clostridium difficile-associated diarrhea (CAD) is a very common nosocomial infection that contributes significantly to patient morbidity and mortality as well as to the cost of hospitalization. Previously, strains of toxin A-negative, toxin B-positive C. difficile were not thought to be associated with clinically significant disease. This study reports the characterization of a toxin A-negative, toxin B-positive strain of C. difficile that was responsible for a recently described nosocomial outbreak of CAD. Analysis of the seven patient isolates from the outbreak by pulsed-field gel electrophoresis indicated that this outbreak was due to transmission of a single strain of C. difficile. Our characterization of this strain (HSC98) has demonstrated that the toxin A gene lacks 1.8 kb from the carboxy repetitive oligopeptide (CROP) region but apparently has no other major deletions from other regions of the toxin A or toxin B gene. The remaining 1.3-kb fragment of the toxin A CROP region from strain HSC98 showed 98% sequence homology with strain 1470, previously reported by M. Weidmann in 1997 (GenBank accession number Y12616), suggesting that HSC98 is toxinotype VIII. The HSC98 strain infecting patients involved in this outbreak produced the full spectrum of clinical illness usually associated with C. difficile-associated disease. This pathogenic spectrum was manifest despite the inability of this strain to alter tight junctions as determined by using in vitro tissue culture testing, which suggested that no functional toxin A was produced by this strain.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10878068      PMCID: PMC87004     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  36 in total

1.  Comparative sequence analysis of the Clostridium difficile toxins A and B.

Authors:  C von Eichel-Streiber; R Laufenberg-Feldmann; S Sartingen; J Schulze; M Sauerborn
Journal:  Mol Gen Genet       Date:  1992-05

Review 2.  Clostridium difficile toxin A and its effects on cells.

Authors:  C Fiorentini; M Thelestam
Journal:  Toxicon       Date:  1991       Impact factor: 3.033

3.  Clostridium difficile: a pathogen of the nineties.

Authors:  T V Riley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-03       Impact factor: 3.267

4.  Separate isolation of Clostridium difficile spores and vegetative cells from the feces of newborn infants.

Authors:  S Miyazaki; T Matsunaga; K Kawasaki; I Kobayashi; H Tada; K Yamaguchi; S Goto
Journal:  Microbiol Immunol       Date:  1992       Impact factor: 1.955

5.  Demonstration of toxin A and B by polymerase chain reaction and McCoy cell assay in clinical isolates of Clostridium difficile from Denmark.

Authors:  J D Knudsen; M Tvede
Journal:  APMIS       Date:  1993-01       Impact factor: 3.205

6.  Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection.

Authors:  C R Clabots; S Johnson; M M Olson; L R Peterson; D N Gerding
Journal:  J Infect Dis       Date:  1992-09       Impact factor: 5.226

7.  Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile.

Authors:  D M Lyerly; L A Barroso; T D Wilkins; C Depitre; G Corthier
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

8.  Molecular, immunological, and biological characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile.

Authors:  S P Borriello; B W Wren; S Hyde; S V Seddon; P Sibbons; M M Krishna; S Tabaqchali; S Manek; A B Price
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

9.  Clostridium difficile toxin B disrupts the barrier function of T84 monolayers.

Authors:  G Hecht; A Koutsouris; C Pothoulakis; J T LaMont; J L Madara
Journal:  Gastroenterology       Date:  1992-02       Impact factor: 22.682

10.  Identification of toxin A-negative, toxin B-positive Clostridium difficile by PCR.

Authors:  H Kato; N Kato; K Watanabe; N Iwai; H Nakamura; T Yamamoto; K Suzuki; S M Kim; Y Chong; E B Wasito
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948

View more
  60 in total

Review 1.  Clostridium difficile testing: after 20 years, still challenging.

Authors:  Tracy D Wilkins; David M Lyerly
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

Review 2.  Clostridium difficile toxins: mechanism of action and role in disease.

Authors:  Daniel E Voth; Jimmy D Ballard
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

3.  Evaluation of two rapid immunochromatography tests for the detection of Clostridium difficile toxins.

Authors:  Zmira Samra; Avia Luzon; Jihad Bishara
Journal:  Dig Dis Sci       Date:  2007-11-08       Impact factor: 3.199

4.  Genotypic investigation of Clostridium difficile in Prince Edward Island.

Authors:  H Martin; L P Abbott; D E Low; B Willey; M Mulvey; J Scott Weese
Journal:  Can J Infect Dis Med Microbiol       Date:  2008-11       Impact factor: 2.471

5.  Emergence of Clostridium difficile NAP1 in Latin America.

Authors:  Carlos Quesada-Gómez; César Rodríguez; María del Mar Gamboa-Coronado; Evelyn Rodríguez-Cavallini; Tim Du; Michael R Mulvey; Manuel Villalobos-Zúñiga; Ricardo Boza-Cordero
Journal:  J Clin Microbiol       Date:  2009-11-25       Impact factor: 5.948

6.  Both, toxin A and toxin B, are important in Clostridium difficile infection.

Authors:  Sarah A Kuehne; Stephen T Cartman; Nigel P Minton
Journal:  Gut Microbes       Date:  2011-07-01

7.  Application of isothermal helicase-dependent amplification with a disposable detection device in a simple sensitive stool test for toxigenic Clostridium difficile.

Authors:  Wing Huen A Chow; Cindy McCloskey; Yanhong Tong; Lin Hu; Qimin You; Ciarán P Kelly; Huimin Kong; Yi-Wei Tang; Wen Tang
Journal:  J Mol Diagn       Date:  2008-07-31       Impact factor: 5.568

8.  Six rapid tests for direct detection of Clostridium difficile and its toxins in fecal samples compared with the fibroblast cytotoxicity assay.

Authors:  David K Turgeon; Thomas J Novicki; John Quick; LaDonna Carlson; Pat Miller; Bruce Ulness; Anne Cent; Rhoda Ashley; Ann Larson; Marie Coyle; Ajit P Limaye; Brad T Cookson; Thomas R Fritsche
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

9.  Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates.

Authors:  Patrizia Spigaglia; Paola Mastrantonio
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

10.  High frequency of antibiotic-associated diarrhea due to toxin A-negative, toxin B-positive Clostridium difficile in a hospital in Japan and risk factors for infection.

Authors:  M Komatsu; H Kato; M Aihara; K Shimakawa; M Iwasaki; Y Nagasaka; S Fukuda; S Matsuo; Y Arakawa; M Watanabe; Y Iwatani
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-08-21       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.